Indoco Remedies Receives Seven USFDA Form 483 Observations At Goa Plant

USFDA inspected Indoco’s Goa Plant II sterile facility from 27 August to 4 September 2026 and issued seven Form 483 observations. The company will submit a response within the stipulated timeframe. Context: the inspection does not yet resolve the plant’s longstanding regulatory overhang.